Company Filing History:
1 out of 15,488 
1 out of 42 Years Active: 1998
Title: The Innovative Contributions of Nan Ping Wang
Introduction
Nan Ping Wang is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the therapeutic applications of the retinoblastoma susceptibility gene product. His work has implications for cancer treatment and prevention.
Latest Patents
Wang holds 1 patent for his invention titled "Therapeutic use of the retinoblastoma susceptibility gene product." This invention provides a method for preventing or inhibiting the proliferation of pathologically proliferating cells. The method addresses the absence of a functional retinoblastoma protein or polypeptide in the cell. By contacting the cell with an effective amount of retinoblastoma protein or polypeptide, this method can prevent or treat retinoblastoma or secondary cancers associated with it.
Career Highlights
Throughout his career, Wang has worked with prestigious institutions, including the University of California and Canji Inc. His research has focused on the mechanisms of cancer proliferation and the potential for therapeutic interventions.
Collaborations
Wang has collaborated with esteemed colleagues such as Wen-Hwa Lee and Eva Y-hp Lee. Their joint efforts have contributed to advancements in cancer research and treatment methodologies.
Conclusion
Nan Ping Wang's innovative work in the field of biotechnology exemplifies the impact of research on cancer treatment. His contributions continue to influence the scientific community and offer hope for patients affected by retinoblastoma and related conditions.